The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021.

ABSTRACT:

Background and objective

Hong Kong, like many parts of Asia, faces a high burden of hepatocellular carcinoma (HCC) caused by high endemic rates of hepatitis B virus infection. Hong Kong clinicians have developed a high level of expertise in HCC treatment across surgical, transarterial, ablative, radiotherapeutic and systemic modalities. This publication summarizes the latest evidence-based recommendations on how these modalities should be used.

Methods

In two meetings held in 2020, a multidisciplinary panel of surgeons, oncologists and interventional radiologists performed a narrative review of evidence on the management of HCC, with an emphasis on treatment of HCC not amenable to surgical resection. Close attention was paid to new evidence published since the previous versi

SUBMITTER: Cheung TT 

PROVIDER: S-EPMC10282685 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature